MARKETS

Company Info

INCOME STATEMENTS

Sun Pharma Advanced Research Company Ltd.

You can view the income statements for the last 5 years.

BSE

Aug 24, 04:01

195.05 -1.75 ( -0.89%)

Volume 39750

Prev. Close 196.80

Open Price 198.15

Today's Low / High

194.00

200.10

Bid Price(Qty.) 0.00 (0)

Open Pr.(Qty.) 0.00 (0)

52 Wk Low / High

108.20

289.00

NSE

Aug 24, 03:59

195.04 -1.67 ( -0.85%)

Volume 364691

Prev. Close 196.71

Open Price 198.75

Today's Low / High

193.99

200.41

Bid Price(Qty.) 195.04 (724)

Open Pr.(Qty.) 0.00 (0)

52 Wk Low / High

108.00

289.00

ISIN No	INE232I01014	Market Cap. ( ₹ in Cr. )	6329.47	P/BV	4.80	Book Value ( ₹ )	40.61
BSE Code	532872	52 Week High/Low ( ₹ )	289/108	FV/ML	1/1	P/E(X)	4.08
NSE Code	SPARCEQ	Book Closure	30/09/2020	EPS ( ₹ )	47.86	Div Yield (%)	0.00

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23
Months	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00


INCOME
Revenue From Operations [Net]	39.15	71.77	75.55	238.78
Other Operating Revenues	1840.02	0.00	0.00	0.00
Total Operating Revenues	1879.17	71.77	75.55	238.78

Other Income	10.95	1.79	29.47	10.88
Total Revenue	1890.12	73.56	105.01	249.66

EXPENSES
Cost Of Materials Consumed	23.60	23.12	28.13	22.11
Operating And Direct Expenses	92.14	173.05	253.81	281.41
Employee Benefit Expenses	118.02	153.58	141.84	107.00
Finance Costs	34.13	9.04	1.69	7.63
Depreciation And Amortisation Expenses	10.21	12.39	12.51	11.77
Other Expenses	46.64	45.15	53.87	42.31
Total Expenses	324.75	416.34	491.85	472.24

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1565.37	-342.78	-386.83	-222.58

Exceptional Items	-12.36	0.00	0.00	0.00
Profit/Loss Before Tax	1553.01	-342.78	-386.83	-222.58

Tax Expenses-Continued Operations
Current Tax	-0.46	0.73	1.63	0.00
Deferred Tax	0.26	-1.01	-1.25	0.00
Total Tax Expenses	-0.19	-0.27	0.38	0.00
Profit/Loss After Tax And Before ExtraOrdinary Items	1553.20	-342.51	-387.21	-222.58

Profit/Loss From Continuing Operations	1553.20	-342.51	-387.21	-222.58

Profit/Loss For The Period	1553.20	-342.51	-387.21	-222.58
Consolidated Profit/Loss After MI And Associates	1553.20	-342.51	-387.21	-222.58

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	47.86	-10.55	-11.93	-7.82
Diluted EPS (Rs.)	47.86	-10.55	-11.93	-7.82

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	1.00

INCOME
Revenue From Operations [Net]	39.15
Other Operating Revenues	1840.02
Total Operating Revenues	1879.17
Other Income	10.95
Total Revenue	1890.12
EXPENSES
Cost Of Materials Consumed	23.60
Operating And Direct Expenses	92.14
Employee Benefit Expenses	118.02
Finance Costs	34.13
Depreciation And Amortisation Expenses	10.21
Other Expenses	46.64
Total Expenses	324.75
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1565.37
Exceptional Items	-12.36
Profit/Loss Before Tax	1553.01
Tax Expenses-Continued Operations
Current Tax	-0.46
Deferred Tax	0.26
Total Tax Expenses	-0.19
Profit/Loss After Tax And Before ExtraOrdinary Items	1553.20
Profit/Loss From Continuing Operations	1553.20
Profit/Loss For The Period	1553.20
Consolidated Profit/Loss After MI And Associates	1553.20
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	47.86
Diluted EPS (Rs.)	47.86

MARKETS

Company Information

INCOME STATEMENTS

Sun Pharma Advanced Research Company Ltd.

BSE

NSE